CROs working on Small Molecule

Matching companies

• AAPharmaSyn

  Medicinal chemistry CRO specializing in custom lipid synthesis, stable isotope labeling, hit-to-lead optimization, and process development for pharmaceutical and biotech clients since 2006.

• ACM Global Laboratories

  Global clinical trial central lab and bioanalytical services provider with 40+ years of experience supporting drug development across 65+ countries.

• ARSI Canada Inc

  ARSI Canada is a specialized CRO offering custom synthesis, API scale-up, analytical method development, and drug development services with over 50 years of combined experience and a GMP manufacturing facility in Bangladesh.

• Accelera Srl

  Europe-based preclinical CRO specializing in GLP-compliant toxicology, safety assessment, and efficacy testing for small molecules and biologics, with AAALAC accreditation and integrated translational research capabilities.

• Aldeyra Therapeutics

  Biopharmaceutical company developing immunomodulatory therapies for immune-mediated ocular and systemic diseases, with late-stage clinical candidates targeting dry eye disease, allergic conjunctivitis, and retinal conditions.

• Aliri Bioanalysis

  Bioanalytical CRO specializing in PK/PD, biomarker, and spatial imaging services across discovery through Phase 3 clinical trials, with 20+ years of regulatory expertise.

• Allucent

  Allucent is a full-service CRO specializing in clinical development solutions for small and mid-sized biotech companies.

• Altasciences

  Mid-size early phase CRO/CDMO in Canada and the U.S. offering preclinical safety testing, clinical pharmacology (Phase I–II), bioanalysis, research services, and manufacturing with integrated capabilities.

• Aragen Life Sciences

  Global CRDMO partner offering integrated discovery-to-commercialization services across small molecules and biologics, with 4000+ scientists and R&D/manufacturing campuses in Asia, North America, and Europe.

• Ardena

  Ardena is an integrated CDMO and bioanalytical CRO specializing in advanced drug product development, nanomedicine, and bioanalysis for complex molecules including poorly soluble compounds, highly potent APIs, and controlled substances.

• Aurigene Pharmaceutical Services Limited

  Integrated CRO-CDMO with 25+ years of discovery and development expertise across small and large molecules, operating 16 US FDA-inspected cGMP facilities across three manufacturing countries.

• BioAgilytix

  Bioanalytical CRO specializing in pharmacokinetics, immunogenicity, biomarkers, and CMC analytics with 30+ years of experience and 1,100+ employees conducting 5M+ tests annually.

• BioDuro-Sundia

  BioDuro-Sundia is a contract research, development, and manufacturing organization (CRDMO) with 30 years of expertise providing integrated drug discovery, development, and manufacturing services from target identification through IND submission.

• Biotest Facility

  Danish CRO offering in vivo models, proteomics, transcriptomics, biomarker discovery, and bioinformatics to support biotech and pharma research from concept to validated data.

• CanAm Bioresearch Inc.

  Medicinal chemistry CRO offering drug discovery, custom organic synthesis, and analytical chemistry services with an all-Ph.D. team and 25+ years of experience.

• Cardiomedex

  Cardiomedex is a preclinical CRO specialized in cardiovascular disease models, offering in vivo efficacy studies, ex vivo functional exploration, and in vitro assays for drug candidates targeting heart failure, myocardial infarction, hypertension, and cardiometabolic complications.

• Celerion

  Global CRO specializing in early-phase clinical research and bioanalytical sciences with 650+ beds across 30 countries and 50+ years of experience.

• Certara

  Certara transforms drug development with proprietary biosimulation software, predictive modeling, and AI-driven services spanning discovery through commercialization. Serving 2,400+ biopharmaceutical companies and regulatory agencies across 70 countries, Certara's model-informed drug development (MIDD) platform accelerates clinical and regulatory decision-making.

• Champions Oncology

  Leading oncology CRO specializing in preclinical and clinical specialty testing, with over 1,400 patient-derived xenograft models, comprehensive multi-omic datasets, and proprietary platforms including flow cytometry, NGS, proteomics, and histopathology services.

• Charles River Laboratories

  Charles River Laboratories provides contract research, development, and manufacturing services across the full drug discovery and development continuum, supporting 80% of FDA-approved drugs over the past five years.

• ChemPartner

  Global preclinical CRO with 20+ years of experience supporting drug discovery through IND submission across small molecules and biologics, with 2,000+ scientists and facilities worldwide.

• Clario

  Clario provides comprehensive clinical trial endpoint solutions spanning cardiac safety, eCOA, medical imaging, respiratory, and precision motion analysis, supporting approximately 70% of FDA and EMA novel drug approvals over the past decade.

• Crown Bioscience

  Preclinical oncology CRO offering 2,500+ PDX models, organoid and cell line databases, and translational platforms with biomarker discovery and AI-driven systems biology for drug development.

• Emery Pharma

  Full-service CRO delivering analytical, bioanalytical, and microbiology services across small molecules, biologics, gene therapy, and botanical drugs from discovery through clinical development.

• Ergomed Clinical Research

  Ergomed is a specialized CRO with 25+ years of experience delivering oncology, rare disease, and complex clinical trial solutions across all phases globally, backed by a team of 100+ MDs and PhDs.

• Evotec

  Evotec is a life science company pioneering drug discovery and preclinical development. The organization leverages cutting-edge technology, disruptive science, and extensive disease knowledge to accelerate the journey from concept to cure.

• Fortrea

  Fortrea is a leading CRO advancing clinical trials through patient-focused clinical solutions that accelerate clinical development and drive trial success.

• Frontage Laboratories

  Global pharmaceutical development organization offering integrated drug discovery, preclinical safety/toxicology, DMPK, bioanalytical, and clinical trial services across 28 sites with 2,200 employees and 200+ FDA inspections.

• ICON plc

  ICON is a global clinical research organization providing full-service drug development and clinical trial solutions across early phase through post-marketing, including clinical operations, bioanalytical labs, cardiac safety, medical imaging, and regulatory affairs.

• IQVIA

  IQVIA is a global life sciences and healthcare company providing data, expertise, AI, analytics, and technology solutions to support clinical development and improve patient outcomes.

• ITR Laboratories

  GLP-compliant nonclinical CRO specializing in safety and toxicology testing across in silico, in vitro, and in vivo modalities, with 35+ years of experience and nearly 6,000 completed studies.

• Innovate Research

  Indian CRO providing end-to-end clinical trial services (Phase I–IV), regulatory support, medical writing, biostatistics, data management, and biospecimen procurement across pharmaceuticals, biologics, medical devices, and nutraceuticals.

• KCAS Bio

  Leading bioanalytical CRO with 45+ years of experience, supporting 315+ approved drugs through bioanalysis, biomarker, immunogenicity, flow cytometry, and clinical kitting services across US, EU, and Australia facilities.

• Labcorp

  Labcorp is a global life sciences and healthcare company offering diagnostic testing, clinical laboratory services, and biopharma support. Labcorp Early Development Services supports nonclinical research, central laboratory work, and early-phase development for drug programs.

• Lindus Health

  Lindus Health is a clinical research organization delivering end-to-end trial execution across Phase 1–2a programs with proprietary AI-driven patient recruitment, integrated site networks, and performance-based pricing. The company has completed 45+ trials with 82% on-time enrollment and operates across the US, UK, and Europe.

• MMS Holdings

  Data-focused CRO providing full-spectrum biometrics, regulatory submissions, safety & risk management, and therapeutic expertise across oncology, CNS, rare diseases, and psychedelics. Named Best Specialist CRO at the Scrip Awards with zero refusals to file on 50+ marketing applications in five years.

• Medpace

  Full-service CRO with 30+ years of organic growth, offering integrated clinical development services across all phases with wholly-owned central labs, bioanalytical lab, imaging core lab, and Phase I unit.

• Noble Life Sciences

  Advanced preclinical CRO providing comprehensive drug and device development services including bioanalysis, GLP toxicology, pharmacodynamic modeling, and specialized testing for oncology, infectious disease, gene therapy, and synthetic biology programs.

• Nuvisan

  Full-service CRO and CDMO with specialized competency centers in drug discovery, formulation development, GMP manufacturing, and bioanalytical services across Germany and France.

• Oncodesign Services

  Contract research organization specializing in drug discovery and preclinical services for oncology, inflammation, and infectious diseases since 1995.

• PPD

  PPD is a leading global contract research organization (CRO) and the clinical research business of Thermo Fisher Scientific.

• Pharmaron

  Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.

• PozeSCAF Inc.

  Preclinical drug discovery CRO combining proprietary generative AI platform AxDrug with computational chemistry, synthetic chemistry, and in vitro biology to accelerate hit discovery and lead optimization for biotech and pharma clients.

• Premier Research

  Premier Research is a global full-service CRO delivering clinical research and development solutions across the complete drug development lifecycle. The organization provides comprehensive capabilities spanning study design, study startup, medical affairs, biostatistics and data management, central monitoring, clinical monitoring and site management, project and risk management, safety and pharmacovigilance, quality and compliance, and medical writing.

• Reaction Biology

  Global preclinical CRO specializing in kinase drug discovery, cell-based assays, in vivo pharmacology, and immuno-oncology with 1,000+ cell lines and hundreds of validated protein targets across US and EU facilities.

• ResolveMass Laboratories Inc.

  Canadian CRO and CDMO specializing in polymer synthesis, peptide characterization, and advanced analytical services for drug delivery and pharmaceutical development. FDA-registered and ISO 9001:2015 certified, serving North American pharmaceutical and biotech companies.

• Simbec-Orion

  Full-service CRO delivering clinical trial management across early to late phases, with specialist expertise in rare diseases and oncology.

• SteerOn Research

  Discovery chemistry CRO offering computational, medicinal, synthetic, and analytical chemistry services alongside regulatory support including PDE/OEL assessments, genotoxicity evaluations, and pharmacovigilance for pharmaceutical and biotech clients.

• Syneos Health

  Global CRO with 26,000+ employees offering integrated clinical development, regulatory affairs, and commercialization services. Helped develop or commercialize 96% of FDA-approved oncology drugs and 93% of EMA-authorized oncology products in the last five years.

• Syngene International

  Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.